Arcturus Therapeutics

Forecast & Rating13 analysts currently cover Arcturus Therapeutics, with about 76.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $20.20, about 30.8% upside from the current price of $15.44. Price targets range from $8.00 to $40.00 — a wide spread, showing clear disagreement over just how much Arcturus Therapeutics can rise. For you, this means most professionals who study Arcturus Therapeutics closely still see room for the stock to rise. Data as of Aug 25, 2026; for reference only and not investment advice.